Monsanto Company (MON) Holdings Raised by Pinebridge Investments L.P.
Pinebridge Investments L.P. boosted its position in shares of Monsanto Company (NYSE:MON) by 26.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,030 shares of the basic materials company’s stock after acquiring an additional 1,453 shares during the period. Pinebridge Investments L.P.’s holdings in Monsanto were worth $843,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. FDO Partners LLC grew its holdings in Monsanto by 690.6% during the 3rd quarter. FDO Partners LLC now owns 27,441 shares of the basic materials company’s stock valued at $3,288,000 after buying an additional 23,970 shares in the last quarter. Tredje AP fonden grew its holdings in Monsanto by 89.3% during the 3rd quarter. Tredje AP fonden now owns 79,687 shares of the basic materials company’s stock valued at $9,548,000 after buying an additional 37,600 shares in the last quarter. Commerzbank Aktiengesellschaft FI grew its holdings in Monsanto by 15.7% during the 3rd quarter. Commerzbank Aktiengesellschaft FI now owns 42,980 shares of the basic materials company’s stock valued at $5,150,000 after buying an additional 5,821 shares in the last quarter. Harding Loevner LP grew its holdings in Monsanto by 140.0% during the 3rd quarter. Harding Loevner LP now owns 2,294,152 shares of the basic materials company’s stock valued at $111,903,000 after buying an additional 1,338,271 shares in the last quarter. Finally, Mint Tower Capital Management B.V. purchased a new stake in Monsanto during the 3rd quarter valued at approximately $479,000. Institutional investors own 75.70% of the company’s stock.
In related news, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of the firm’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now directly owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. Over the last three months, insiders sold 49,236 shares of company stock valued at $5,931,934. 0.79% of the stock is currently owned by insiders.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm had revenue of $2.69 billion during the quarter, compared to analyst estimates of $2.51 billion. During the same period last year, the firm posted $0.07 earnings per share. Monsanto’s revenue for the quarter was up 4.8% compared to the same quarter last year. research analysts predict that Monsanto Company will post 5.74 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s dividend payout ratio (DPR) is presently 42.27%.
A number of brokerages have issued reports on MON. Royal Bank Of Canada reaffirmed a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Wells Fargo & Company increased their price objective on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Barclays reaffirmed an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price objective on shares of Monsanto in a report on Thursday, October 5th. Finally, Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Eleven investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Monsanto currently has an average rating of “Hold” and a consensus target price of $124.61.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/12/10/monsanto-company-mon-holdings-raised-by-pinebridge-investments-l-p.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.